Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Acta Medica Philippina ; : 4-13, 2012.
Article in English | WPRIM | ID: wpr-631802

ABSTRACT

Objective. The present study aims to correlate the LGU list of PhilHealth Sponsored Members in a municipality of Batangas with the list of poor residents as identified by the Participatory Action Research (PAR) methodology. Method. Interview of key informants documented the processes utilized by the LGU in determining PhilHealth beneficiaries for the Sponsored Program and the Participatory Action Research (PAR) survey in the classification of households into poor, middle and rich in four barangays of the municipality. The list of LGU Sponsored members was then cross matched with the PAR household classification. Results. The comparison of the LGU list of Sponsored members and the household classification by the PAR survey showed a wide discrepancy: (1) 464 "Not Found" Sponsored households or 70% of the LGU's Sponsored list; (2) inclusion of the non-poor: 140 middle class families as classified by the PAR survey or 21.1% of the LGU's Sponsored list; and (3) exclusion of 413 or 87.5% of true poor families identified by the PAR Survey. Only 59 families or 8.9% of the LGU Sponsored list were classified as poor families by PAR. Conclusion. PAR offers communities, LGUs and the National Health Insurance Program a tool to validate the coverage of the Sponsored program. LGUs and the PhilHealth should consider such tool or similar tools to validate their identification, selection and enrollment of the poor, which is extremely vital in achieving universal coverage. Given the right tool, communities are in the best position to identify the poor for the Sponsored program. By way of collaboration with the underprivileged themselves, the academe has a role in assisting communities in acquiring collective awareness of their own situation and developing capacity for improving their lives. The academe also has a role in assisting LGUs in improving their health systems and national health programs in validating and improving their implementation. Further studies should be done to investigate the following: the identity of the "not found" SP members; the utilization of PhilHealth benefits by the poor; and the prospect of utilizing the PAR method by other non-academic institutions in monitoring the progress of community programs.


Subject(s)
Humans , Male , Female , Public-Private Sector Partnerships , Health Services , Insurance, Health , Health Care Economics and Organizations , Economics , Financing, Organized , Insurance
2.
Acta Medica Philippina ; : 4-13, 2012.
Article in English | WPRIM | ID: wpr-633753

ABSTRACT

OBJECTIVE: The present study aims to correlate the LGU list of PhilHealth Sponsored Members in a municipality of Batangas with the list of poor residents as identified by the Participatory Action Research (PAR) methodology. METHOD: Interview of key informants documented the processes utilized by the LGU in determining PhilHealth beneficiaries for the Sponsored Program and the Participatory Action Research (PAR) survey in the classification of households into poor, middle and rich in four barangays of the municipality. The list of LGU Sponsored members was then cross matched with the PAR household classification. RESULTS:The comparison of the LGU list of Sponsored members and the household classification by the PAR survey showed a wide discrepancy: (1) 464 "Not Found" Sponsored households or 70% of the LGU's Sponsored list; (2) inclusion of the non-poor: 140 middle class families as classified by the PAR survey or 21.1% of the LGU's Sponsored list; and (3) exclusion of 413 or 87.5% of true poor families identified by the PAR Survey. Only 59 families or 8.9% of the LGU Sponsored list were classified as poor families by PAR. CONCLUSION:PAR offers communities, LGUs and the National Health Insurance Program a tool to validate the coverage of the Sponsored program. LGUs and the PhilHealth should consider such tool or similar tools to validate their identification, selection and enrollment of the poor, which is extremely vital in achieving universal coverage. Given the right tool, communities are in the best position to identify the poor for the Sponsored program. By way of collaboration with the underprivileged themselves, the academe has a role in assisting communities in acquiring collective awareness of their own situation and developing capacity for improving their lives. The academe also has a role in assisting LGUs in improving their health systems and national health programs in validating and improving their implementation. Further studies should be done to investigate the following: the identity of the "not found" SP members; the utilization of PhilHealth benefits by the poor; and the prospect of utilizing the PAR method by other non-academic institutions in monitoring the progress of community programs.


Subject(s)
Humans , Male , Female , Universal Health Insurance , Health Services Research , Family Characteristics , National Health Programs , Vulnerable Populations
3.
Indian J Pediatr ; 2004 Jun; 71(6): 495-9
Article in English | IMSEAR | ID: sea-82909

ABSTRACT

OBJECTIVE: To investigate the sources of lead in the environment in children with elevated blood, with the help of a Field Portable X-Ray Fluorescence Analyzer. METHODS: One hundred and seven school children were chosen for this study on a random basis, from Mangalore and Karnataka. Their blood lead was analyzed. Of the cases analyzed, 10 students whose blood lead level was more than 40 microg/dl were investigated using a field portable X-Ray Fluorescence Analyzer. This is the first time such a device has been available for this purpose in India. RESULTS: The 'likely' source of lead exposure could be determined in eight cases which was from the immediate environment of the children like 'lead-based' paint on surfaces in the house, on playground and other exterior equipment; lead storage batteries, contaminated dust and soil and other lead-containing substances. CONCLUSION: The use of an X-Ray Fluorescence Analyser appeared to be useful in determining the source of lead.


Subject(s)
Child , Environmental Exposure/analysis , Environmental Monitoring/instrumentation , Fluorescence , Humans , India , Lead/blood , Soil Pollutants/analysis
6.
Southeast Asian J Trop Med Public Health ; 1976 Jun; 7(2): 263-9
Article in English | IMSEAR | ID: sea-36263

ABSTRACT

Combined clinico-pathological and laboratory examinations were carried out on 52 S. japonicum infected patients from an endemic area in Central Sulawesi, Indonesia. All of these patients exhibited signs and symptoms of chronic hepato-splenic schistosomiasis. None of the patients showed evidence of liver cirrhosis on histopathological examination. However, varying degrees of portal fibrosis were exhibited. The correlation between the degree of fibrosis and the clinical and laboratory findings were presented and discussed. Based on the results, liver biopsy proved to be a vaulable method of diagnosis in this particular type of infection. This study provides new information on S. japonicum infection in the area and may support a more solid basis for treatment.


Subject(s)
Adolescent , Adult , Feces/parasitology , Female , Humans , Indonesia , Liver/pathology , Male , Parasite Egg Count , Schistosoma/isolation & purification , Schistosomiasis/diagnosis , Species Specificity
7.
Southeast Asian J Trop Med Public Health ; 1976 Jun; 7(2): 314-8
Article in English | IMSEAR | ID: sea-35058

ABSTRACT

A limited drug trial was carried out on 42 cases with schistosomiasis japonica from an endemic area of Central Sulawesi. The drugs used were niridazole and stibophen. The effects of treatment were reported and discussed. The results of this study offer promise for treating S. japonicum infection in Central Sulawesi on a larger scale.


Subject(s)
Adolescent , Adult , Benzenesulfonates/adverse effects , Clinical Trials as Topic , Female , Humans , Indonesia , Male , Niridazole/adverse effects , Schistosoma/isolation & purification , Schistosomiasis/drug therapy , Schistosomicides/therapeutic use , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL